Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-26

Clinical Trial Update: Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum [Phase 2]

View source ↗

Summary

Pfizer-sponsored Phase 2 trial evaluating azithromycin with chloroquine versus chloroquine alone for eradication of asymptomatic Plasmodium falciparum malaria w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Chloroquine (chloroquine)

Snippet

Sponsor: Pfizer | Conditions: Malaria, Falciparum | Phase 2 | Status: TERMINATED